Xiaotong Hou
Clinical trials sponsored by Xiaotong Hou, explained in plain language.
-
ECMO patients may get safer blood thinner in new trial
Disease control Recruiting nowThis study tests whether bivalirudin, a newer blood thinner, is safer and more effective than the standard drug heparin for patients on ECMO (a machine that helps the heart and lungs). The trial will enroll 154 adults on ECMO and track how many develop dangerous clots or bleeding…
Phase: NA • Sponsor: Xiaotong Hou • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New blood thinner could reduce clot risks in heart surgery recovery
Disease control Recruiting nowThis study compares a drug called nafamostat mesilate to the standard blood thinner heparin in 80 adults who need a heart-lung machine (ECMO) after heart surgery. The goal is to see which drug better prevents dangerous blood clots while causing fewer bleeding problems. Participan…
Phase: NA • Sponsor: Xiaotong Hou • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC